Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100009/S077

MitraClip G5 Delivery System

ABBOTT MEDICAL · Decision date Jul 23, 2025

FDA DECISIONP100009/S077

What did the FDA decide?

FDA records P100009/S077 as a supplement to PMA P100009, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 23, 2025.

FDA approval order statement

to implement an additional manufacturing site for the MitraClip G5 Delivery System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 23, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P100009/S077
Regulatory pathway
PMA supplement
Product code
NKM
Decision code
OK30
Decision date
Jul 23, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Mitral valve repair devices.

Product code
NKM
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P100009/S077 received

    Application receipt date recorded by FDA.

  2. P100009/S077 · FDA decision

    30-Day Notice

  3. P100009/S079 · Related supplement

    MitraClip Delivery System

  4. P100009/S078 · Related supplement

    MitraClip G5 Delivery System

  5. P100009/S080 · Related supplement

    MitraClip G4 Clip Delivery System; MitraClip G5 Delivery System

  6. P100009/S081 · Related supplement

    MITRACLIP DELIVERY SYSTEM

  7. P100009/S082 · Related supplement

    MitraClip G5 Delivery System (CDS0801-NT, CDS0801-NTW, CDS0801-XT, CDS0801-XTW)

  8. P100009/S083 · Related supplement

    MitraClip NTR/XTR Clip Delivery System; MitraClip G4 System

  9. P100009/S085 · Related supplement

    MitraClip Delivery Systems

Timeline entries are records held by MedtechLedger for P100009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100009

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementAug 18, 2025FDA
ABBOTT MEDICALPMA supplementAug 20, 2025FDA
ABBOTT MEDICALPMA supplementSep 30, 2025FDA
ABBOTT MEDICALPMA supplementOct 17, 2025FDA
ABBOTT MEDICALPMA supplementFeb 25, 2026FDA
ABBOTT MEDICALPMA supplementMar 6, 2026FDA
MitraClip SystemsP100009/S084
ABBOTT MEDICALPMA supplementMay 14, 2026FDA
ABBOTT MEDICALPMA supplementMay 28, 2026FDA
MitraClip SystemsP100009/S086
ABBOTT MEDICALPMA supplementJun 25, 2026FDA

Explore the linked device profile

Other records with product code NKM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records